AI
ETON icon

Acuitas Investments’s Eton Pharmaceutcials ETON Stock Holding History

Acuitas Investments’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-185,824
Closed -$2.48M – 74
2024
Q4 		$2.48M Sell
185,824
-394,136
-68% -$4M 2.03% 25
2024
Q3 		$3.48M Hold
579,960
– – 1.55% 19
2024
Q2 		$1.91M Hold
579,960
– – 1.02% 39
2024
Q1 		$2.17M Buy
579,960
+87,906
+18% +$384K 1.1% 37
2023
Q4 		$2.16M Buy
492,054
+273,054
+125% +$1.09M 1.13% 33
2023
Q3 		$913K Sell
219,000
-291,054
-57% -$1.12M 0.54% 65
2023
Q2 		$1.78M Buy
510,054
+41,367
+9% +$152K 1.04% 39
2023
Q1 		$1.8M Buy
+468,687
New +$1.71M 1.86% 26

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acuitas Investments's ETON Position: Q1 2025 in Review

Acuitas Investments sold out of Eton Pharmaceutcials (ETON) in Q1 2025, closing a stake of 185,824 shares — an estimated $2.48M sold.

Acuitas Investments first reported a position in ETON in Q1 2023 and held it in 8 quarters. The position peaked at $3.48M in Q3 2024. 86 funds tracked by Wall St. Rank hold ETON as of Q1 2025.

  • Acuitas Investments reported no remaining Eton Pharmaceutcials position as of Q1 2025 after selling out during the quarter.
  • Acuitas Investments sold 185,824 Eton Pharmaceutcials shares in Q1 2025, an estimated $2.48M.
  • Acuitas Investments first reported a position in Eton Pharmaceutcials in Q1 2023 and held it in 8 quarters.
  • Acuitas Investments's Eton Pharmaceutcials position peaked at $3.48M in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2025.

Based on Acuitas Investments's 13F filing for Q1 2025, filed 28 Apr 2025.